PH+ ALL
Clinical trials for PH+ ALL explained in plain language.
Never miss a new study
Get alerted when new PH+ ALL trials appear
Sign up with your email to follow new studies for PH+ ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for ph+ ALL: targeted combo shows promise
Disease control Recruiting nowThis study is testing a new combination of low-intensity chemotherapy and targeted immunotherapy for people newly diagnosed with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Participants will receive a third-generation TKI drug (olverembatinib) and may…
Matched conditions: PH+ ALL
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New drug combo aims to beat leukemia in phase 3 trial
Disease control Recruiting nowThis phase 3 study tests whether adding the experimental drug olverembatinib to standard chemotherapy works better than the usual targeted therapy (a TKI) plus chemotherapy for people newly diagnosed with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Th…
Matched conditions: PH+ ALL
Phase: PHASE3 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC